Dieter Wolf

Dieter Wolf, M.D.[La Jolla]

  • Director, NCI-designated Cancer Center Proteomics Facility
  • Research

    Dr. Wolf's research focuses on the postranscriptional regulation of tumor-suppressor protein abundance and function.

  • Biography

    Dr. Wolf obtained an M.D. degree from the Ludwig-Maximilian’s University in Munich, Germany in 1995.

Publications

Dieter Wolf's Research Focus

Prostate Cancer

Our research focuses on basic posttranscriptional mechanisms that control protein abundance and function. We concentrate on conserved pathways regulating protein synthesis at the level of translation and protein degradation through the ubiquitin-proteasome system. For many of these studies, we are using the fission yeast Schizosacharomyces pombe as a model system. Our studies also employ a variety of genome-wide approaches such as proteomics and ribonomics. Our goals are (1.) to define translation initiation complexes that mediate stress-specific mRNA translation; (2.) to define and characterize novel substrates of cullin-RING ubiquitin ligases, and (3.) to integrate large scale mRNA and protein expression datasets into a systems view of oxidative stress response. We are also applying insights derived from our studies in fission yeast to the biology of human cancer. In particular, we are seeking ubiquitin ligases targeting several tumor suppressor proteins involved in prostate cancer. We are also performing high-throughput screens for small molecule inhibitors of ectopic degradation of prostate tumor suppressors.
 

About Dieter Wolf

Experience

Dieter Wolf obtained an M.D. degree from the Ludwig-Maximilian’s University in Munich, Germany in 1995. Upon postdoctoral work at Harvard Medical School and Stanford University School of Medicine, he joined the faculty of the Harvard School of Public Health in 1998 as an Assistant Professor advancing to Associate Professor in 2003. In 2007, Dr. Wolf was recruited to Sanford-Burnham Medical Research Institute as Professor in the Signal Transduction Program and Director of the NCI-designated Cancer Center Proteomics Facility.

Become a Partner / Donate
Your support is crucial in turning hope into healing. Your support is crucial in turning hope into healing. Learn More
Social Media

Sign In Skip Navigation Links Skip navigation links
Our Mission
Research
Talent
Technology
Training & Education
Our Supporters
Privacy Policy